Mirabegron induces selective changes in the faecal microbiota of HFHFr rats without altering bile acid composition

In the present work, we analyse stored liver, adipose tissue (perigonadal</p><p>and brown), serum and faecal samples from our previous study and present new</p><p>biochemical, faecal metabolomic and microbiome data.</p><p>We show that oral administration of mirabe...

Full description

Bibliographic Details
Authors: Bentanachs Raset, Roger, Miró Martí, Ma. Lluïsa, Ramírez-Carrasco, Patricia, Sánchez, Rosa María, Bernabeu Lorenzo, Manuel, Amat, Concepció, Alegret i Jordà, Marta, Pérez Bosque, Anna, Roglans i Ribas, Núria, Laguna Egea, Juan Carlos
Format: article
Status:Published version
Publication Date:2025
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/225599
Online Access:https://hdl.handle.net/2445/225599
Access Level:Open access
Keyword:Metabolisme
Malalties del fetge
Teixit adipós
Metabolism
Liver diseases
Adipose tissues
Description
Summary:In the present work, we analyse stored liver, adipose tissue (perigonadal</p><p>and brown), serum and faecal samples from our previous study and present new</p><p>biochemical, faecal metabolomic and microbiome data.</p><p>We show that oral administration of mirabegron</p><p>significantly increases the expression of uncoupling protein 1 in brown</p><p>adipose tissue and β3-Adrenergic receptor protein in perigonadal white</p><p>adipose and liver tissues. Furthermore, mirabegron treatment changes the</p><p>relative abundance of several genus and families of rat faecal microbiota,</p><p>albeit without restoring the global biodiversity and evenness indexes observed</p><p>in control rats, as well as faecal bile acids composition. These changes are</p><p>probably due to a direct effect of mirabegron on the gut microbiome, rather</p><p>than being mediated by changes in bile acid induced by drug treatment.